
Exact Sciences Shares Financial Results for Q1 2025
Exact Sciences Reports First-Quarter 2025 Financial Results, Launches Two New Cancer Detection Tests Exact Sciences Corp. (Nasdaq: EXAS), a global leader in cancer diagnostics and early detection, announced its financial results for the first quarter ended March 31, 2025. The…












